{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:23:32Z","timestamp":1790558612201,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jgar.2022.10.015","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T03:30:16Z","timestamp":1667619016000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9910-156X","authenticated-orcid":false,"given":"Saskia E.","family":"Mudde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie A.","family":"Schildkraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Ammerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corn\u00e9 P.","family":"de Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurriaan E.M.","family":"de Steenwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko","family":"van Ingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore I.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.10.015_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2022.10.015_bib0002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2015.09.007","article-title":"Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis","volume":"15","author":"Qvist","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2022.10.015_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41564-021-00963-3","article-title":"Dissemination of Mycobacterium abscessus via global transmission networks","volume":"6","author":"Ruis","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2022.10.015_bib0004","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jgar.2022.10.015_bib0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0006","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"Wallace","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0007","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1038\/s41598-021-85721-5","article-title":"Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2022.10.015_bib0008","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkt410","article-title":"Characterization of broad-spectrum Mycobacterium abscessus class A \u03b2-lactamase","volume":"69","author":"Soroka","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00119-18","article-title":"High levels of intrinsic tetracycline resistance in Mycobacterium abscessus are conferred by a tetracycline-modifying monooxygenase","volume":"62","author":"Rudra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2022.10.015_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/antibiotics8030153","article-title":"The contribution of efflux pumps in Mycobacterium abscessus Complex resistance to clarithromycin","volume":"8","author":"Vianna","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2022.10.015_bib0012","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/IDR.S239850","article-title":"Efflux pumps contribute to intrinsic clarithromycin resistance in clinical, Mycobacterium abscessus isolates","volume":"13","author":"Guo","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2022.10.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01316-18","article-title":"Mutations in the MAB_2299c tetR regulator confer cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus","volume":"63","author":"Richard","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00175-18","article-title":"Determination of MIC distribution and mechanisms of decreased susceptibility to bedaquiline among clinical isolates of Mycobacterium abscessus","volume":"62","author":"Li","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0015","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/microorganisms9122527","article-title":"Mycobacterium abscessus genetic determinants associated with the intrinsic resistance to antibiotics","volume":"9","author":"Gorzynski","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2022.10.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab050","article-title":"Critical discussion on drug efflux in Mycobacterium tuberculosis","volume":"46","author":"Remm","year":"2022","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jgar.2022.10.015_bib0017","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 5452, Thioridazine. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thioridazine."},{"key":"10.1016\/j.jgar.2022.10.015_bib0018","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 2520, Verapamil. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Verapamil."},{"key":"10.1016\/j.jgar.2022.10.015_bib0019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/jiu095","article-title":"Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs","volume":"210","author":"Adams","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2022.10.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01354-18","article-title":"Assessment of the additional value of verapamil to a moxifloxacin and linezolid combination regimen in a murine tuberculosis model","volume":"62","author":"Pieterman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0021","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgar.2018.12.020","article-title":"Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus","volume":"17","author":"Vianna","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.10.015_bib0022","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/jac\/dkz267","article-title":"Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus","volume":"74","author":"Bax","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01509-21","article-title":"RNA sequencing elucidates drug-specific mechanisms of antibiotic tolerance and resistance in Mycobacterium abscessus","volume":"66","author":"Schildkraut","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0024","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkn070","article-title":"Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis","volume":"61","author":"Rodrigues","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tube.2017.04.010","article-title":"The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs","volume":"105","author":"Bax","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jgar.2022.10.015_bib0026","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3390\/ijms21124191","article-title":"Efflux pump inhibitors against nontuberculous mycobacteria","volume":"21","author":"Rindi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2022.10.015_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00330-21","article-title":"MAB_2355c confers macrolide resistance in Mycobacterium abscessus by ribosome protection","volume":"65","author":"Guo","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01347-17","article-title":"Mycobacterium abscessus whiB7 regulates a species-specific repertoire of genes to confer extreme antibiotic resistance","volume":"61","author":"Hurst-Hess","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01353-17","article-title":"Antagonism between front-line antibiotics clarithromycin and amikacin in the treatment of Mycobacterium abscessus infections is mediated by the whiB7 gene","volume":"61","author":"Pryjma","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0030","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acs.chemrev.0c01226","article-title":"Physiological functions of bacterial \u2018multidrug\u2019 efflux pumps","volume":"121","author":"Henderson","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.jgar.2022.10.015_bib0031","doi-asserted-by":"crossref","first-page":"e01975","DOI":"10.1128\/mBio.01975-15","article-title":"ABC-F proteins mediate antibiotic resistance through ribosomal protection","volume":"7","author":"Sharkey","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2022.10.015_bib0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/microorganisms7030070","article-title":"MmpL proteins in physiology and pathogenesis of M. tuberculosis","volume":"7","author":"Melly","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2022.10.015_bib0033","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1073\/pnas.0507850102","article-title":"Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration","volume":"102","author":"Shi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2022.10.015_bib0034","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JB.01857-07","article-title":"Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration","volume":"190","author":"Sohaskey","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2022.10.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02107-17","article-title":"Verapamil targets membrane energetics in Mycobacterium tuberculosis","volume":"62","author":"Chen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01692-17","article-title":"Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis","volume":"62","author":"Xu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.10.015_bib0037","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2125.2007.03021.x","article-title":"Thioridazine: resurrection as an antimicrobial agent?","volume":"64","author":"Thanacoody","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2022.10.015_bib0038","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/dmpt-2015-0041","article-title":"Severe verapamil intoxication despite correct use of low-dose verapamil","volume":"31","author":"Mandigers","year":"2016","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.jgar.2022.10.015_bib0039","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/crj.13142","article-title":"Therapeutic effects of nebulized verapamil on chronic obstructive pulmonary disease: a randomized and double-blind clinical trial","volume":"14","author":"Bozorgmehr","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jgar.2022.10.015_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejpb.2016.07.014","article-title":"In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment","volume":"107","author":"Parumasivam","year":"2016","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:02:08Z","timestamp":1761991328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"alternative-id":["S2213716522002442"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.10.015","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}